Search research articles
Contact Us
Filters
Showing results (31-40 of 43) with videos related to
Page
of 5
Sort By:
Investigational New Drugs
|
November 11, 2015
First-in-human, phase I/IIa clinical study of the peptidase potentiated alkylator melflufen administered every three weeks to patients with advanced solid tumor malignancies
Åke Berglund, Anders Ullén, Alla Lisyanskaya, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 4, 2023
Single-Cell RNA Analysis Reveals Cell-Intrinsic Functions of CAR T Cells Correlating with Response in a Phase II Study of Lymphoma Patients
Tina Sarén, Mohanraj Ramachandran, Gustav Gammelgård, et al.
Medical Oncology (Northwood, London, England)
|
December 17, 2002
Selection of chemotherapy by ex vivo assessment of tumor sensitivity to cytotoxic drugs: results of a clinical trial
Ake Berglund, Bengt Glimelius, Jonas Bergh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 12, 2018
A Phase I/IIa Trial Using CD19-Targeted Third-Generation CAR T Cells for Lymphoma and Leukemia
Gunilla Enblad, Hannah Karlsson, Gustav Gammelgård, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 22, 2018
Adjuvant chemotherapy and postoperative radiotherapy in high-risk soft tissue sarcoma patients defined by biological risk factors-A Scandinavian Sarcoma Group study (SSG XX)
Kirsten Sundby Hall, Øyvind S Bruland, Bodil Bjerkehagen, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
May 28, 2005
Evaluation of immunophenotype in diffuse large B-cell lymphoma and its impact on prognosis
Mattias Berglund, Ulf Thunberg, Rose-Marie Amini, et al.
Haematologica
|
November 11, 2003
Long-term disease-free survival in patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation
Johannes Schetelig, Sebastian Fetscher, Albrecht Reichle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 27, 2011
T cells in tumors and blood predict outcome in follicular lymphoma treated with rituximab
Björn Engelbrekt Wahlin, Christer Sundström, Harald Holte, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 2, 2012
Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01
Francesco d'Amore, Thomas Relander, Grete F Lauritzsen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 24, 2012
Rituximab maintenance therapy after autologous stem-cell transplantation in patients with relapsed CD20(+) diffuse large B-cell lymphoma: final analysis of the collaborative trial in relapsed aggressive lymphoma
Christian Gisselbrecht, Norbert Schmitz, Nicolas Mounier, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 43) with videos related to
Sort By:
Page
of 5
Investigational New Drugs
|
November 11, 2015
First-in-human, phase I/IIa clinical study of the peptidase potentiated alkylator melflufen administered every three weeks to patients with advanced solid tumor malignancies
Åke Berglund, Anders Ullén, Alla Lisyanskaya, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 4, 2023
Single-Cell RNA Analysis Reveals Cell-Intrinsic Functions of CAR T Cells Correlating with Response in a Phase II Study of Lymphoma Patients
Tina Sarén, Mohanraj Ramachandran, Gustav Gammelgård, et al.
Medical Oncology (Northwood, London, England)
|
December 17, 2002
Selection of chemotherapy by ex vivo assessment of tumor sensitivity to cytotoxic drugs: results of a clinical trial
Ake Berglund, Bengt Glimelius, Jonas Bergh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 12, 2018
A Phase I/IIa Trial Using CD19-Targeted Third-Generation CAR T Cells for Lymphoma and Leukemia
Gunilla Enblad, Hannah Karlsson, Gustav Gammelgård, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 22, 2018
Adjuvant chemotherapy and postoperative radiotherapy in high-risk soft tissue sarcoma patients defined by biological risk factors-A Scandinavian Sarcoma Group study (SSG XX)
Kirsten Sundby Hall, Øyvind S Bruland, Bodil Bjerkehagen, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
May 28, 2005
Evaluation of immunophenotype in diffuse large B-cell lymphoma and its impact on prognosis
Mattias Berglund, Ulf Thunberg, Rose-Marie Amini, et al.
Haematologica
|
November 11, 2003
Long-term disease-free survival in patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation
Johannes Schetelig, Sebastian Fetscher, Albrecht Reichle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 27, 2011
T cells in tumors and blood predict outcome in follicular lymphoma treated with rituximab
Björn Engelbrekt Wahlin, Christer Sundström, Harald Holte, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 2, 2012
Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01
Francesco d'Amore, Thomas Relander, Grete F Lauritzsen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 24, 2012
Rituximab maintenance therapy after autologous stem-cell transplantation in patients with relapsed CD20(+) diffuse large B-cell lymphoma: final analysis of the collaborative trial in relapsed aggressive lymphoma
Christian Gisselbrecht, Norbert Schmitz, Nicolas Mounier, et al.
Page
of 5